138 related articles for article (PubMed ID: 27651919)
1. Increased von Willebrand factor levels in patients with systemic lupus erythematosus reflect inflammation rather than increased propensity for platelet activation.
Nossent JC; Raymond WD; Eilertsen GØ
Lupus Sci Med; 2016; 3(1):e000162. PubMed ID: 27651919
[TBL] [Abstract][Full Text] [Related]
2. A two-centre comparative evaluation of new automated assays for von Willebrand factor ristocetin cofactor activity and antigen.
Stufano F; Lawrie AS; La Marca S; Berbenni C; Baronciani L; Peyvandi F
Haemophilia; 2014 Jan; 20(1):147-53. PubMed ID: 24028703
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Von Willebrand factor (VWF) activity VWF:Ac with VWF ristocetin cofactor activity VWF:RCo.
Geisen U; Zieger B; Nakamura L; Weis A; Heinz J; Michiels JJ; Heilmann C
Thromb Res; 2014 Aug; 134(2):246-50. PubMed ID: 24891215
[TBL] [Abstract][Full Text] [Related]
4. High resolution multimer analysis and the PFA-100 platelet function analyser can detect von Willebrand disease type 2A without a pathological ratio of ristocetin cofactor activity and von Willebrand antigen level.
Weiss DR; Strasser EF; Ringwald J; Zimmermann R; Eckstein R
Clin Lab; 2012; 58(11-12):1203-9. PubMed ID: 23289190
[TBL] [Abstract][Full Text] [Related]
5. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.
Michiels JJ; Budde U; van der Planken M; van Vliet HH; Schroyens W; Berneman Z
Best Pract Res Clin Haematol; 2001 Jun; 14(2):401-36. PubMed ID: 11686107
[TBL] [Abstract][Full Text] [Related]
6. Laboratory testing for von Willebrand's disease: an assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey. RCPA Quality Assurance Program (QAP) in Haematology Haemostasis Scientific Advisory Panel.
Favaloro EJ; Smith J; Petinos P; Hertzberg M; Koutts J
Thromb Haemost; 1999 Oct; 82(4):1276-82. PubMed ID: 10544913
[TBL] [Abstract][Full Text] [Related]
7. Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays?
Favaloro EJ; Thom J; Patterson D; Just S; Dixon T; Koutts J; Baccala M; Rowell J; Baker R
Thromb Res; 2009 Apr; 123(6):862-8. PubMed ID: 19064279
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
Favaloro EJ; Lloyd J; Rowell J; Baker R; Rickard K; Kershaw G; Street A; Scarff K; Barrese G; Maher D; McLachlan AJ
Thromb Haemost; 2007 Jun; 97(6):922-30. PubMed ID: 17549293
[TBL] [Abstract][Full Text] [Related]
9. [The association of von Willebrand factor and von Willebrand factor-cleaving protease in systemic lupus erythematosus].
Lu GY; Guo XF; Wang ZY; Bai X; Su J; Ruan CG
Zhonghua Nei Ke Za Zhi; 2006 Jan; 45(1):42-4. PubMed ID: 16624087
[TBL] [Abstract][Full Text] [Related]
10. Systemic lupus erythematosus complicated by acquired von Willebrand's syndrome.
Hong S; Lee J; Chi H; Lee C; Nah S; Kim Y; Oh J; Moon H; Yoo B
Lupus; 2008 Sep; 17(9):846-8. PubMed ID: 18755868
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of an automated method for measuring von Willebrand factor activity in clinical samples without ristocetin.
Graf L; Moffat KA; Carlino SA; Chan AK; Iorio A; Giulivi A; Hayward CP
Int J Lab Hematol; 2014 Jun; 36(3):341-51. PubMed ID: 24750681
[TBL] [Abstract][Full Text] [Related]
12. Laboratory diagnosis and molecular classification of von Willebrand disease.
Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
[TBL] [Abstract][Full Text] [Related]
13. Decreased von Willebrand factor ristocetin cofactor activity and increased ADAMTS13 antigen increase postoperative drainage after coronary artery bypass grafting.
Mazur P; Plicner D; Zdziarska J; Sadowski J; Undas A
Eur J Cardiothorac Surg; 2014 Feb; 45(2):e26-32. PubMed ID: 24351199
[TBL] [Abstract][Full Text] [Related]
14. Influence of a Rotational Speed Modulation System Used With an Implantable Continuous-Flow Left Ventricular Assist Device on von Willebrand Factor Dynamics.
Naito N; Mizuno T; Nishimura T; Kishimoto S; Takewa Y; Eura Y; Kokame K; Miyata T; Date K; Umeki A; Ando M; Ono M; Tatsumi E
Artif Organs; 2016 Sep; 40(9):877-83. PubMed ID: 26750507
[TBL] [Abstract][Full Text] [Related]
15. Validation of a new panel of automated chemiluminescence assays for von Willebrand factor antigen and activity in the screening for von Willebrand disease.
Verfaillie CJ; De Witte E; Devreese KM
Int J Lab Hematol; 2013 Oct; 35(5):555-65. PubMed ID: 23551532
[TBL] [Abstract][Full Text] [Related]
16. Towards improved diagnosis of von Willebrand disease: comparative evaluations of several automated von Willebrand factor antigen and activity assays.
Favaloro EJ; Mohammed S
Thromb Res; 2014 Dec; 134(6):1292-300. PubMed ID: 25300811
[TBL] [Abstract][Full Text] [Related]
17. Comparison of several von Willebrand factor (VWF) activity assays for monitoring patients undergoing treatment with VWF/FVIII concentrates: improved performance with a new modified automated method.
Hillarp A; Friedman KD; Adcock-Funk D; Tiefenbacher S; Nichols WL; Chen D; Stadler M; Schwartz BA
Haemophilia; 2015 Nov; 21(6):837-45. PubMed ID: 26172561
[TBL] [Abstract][Full Text] [Related]
18. Extracorporeal membrane oxygenation induces short-term loss of high-molecular-weight von Willebrand factor multimers.
Tauber H; Ott H; Streif W; Weigel G; Loacker L; Fritz J; Heinz A; Velik-Salchner C
Anesth Analg; 2015 Apr; 120(4):730-6. PubMed ID: 25565317
[TBL] [Abstract][Full Text] [Related]
19. Development of an ELISA method for testing VWF ristocetin cofactor activity with improved sensitivity and reliability in the diagnosis of von Willebrand disease.
Zhao Y; Gu Y; Ji S; Yang J; Yu Z; Ruan C
Eur J Haematol; 2012 May; 88(5):439-45. PubMed ID: 22268616
[TBL] [Abstract][Full Text] [Related]
20. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.
Turecek PL; Siekmann J; Schwarz HP
Semin Thromb Hemost; 2002 Apr; 28(2):149-60. PubMed ID: 11992238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
